International health and medical experts attended the Medical Innovation 2010 Conference in March, hosted by The George Institute in partnership with University of Oxford Center for Entrepreneurship and Innovation (Saïd Business School).
The George Institute Annual Report has been acknowledged as a Finalist for Australasian Reporting Awards. At the official awards evening in Sydney last night, The George Annual Report was recognised for a Special Award for Communication within the not-for-profit sector.
The George Institute has received funding from the esteemed James Martin 21st Century School. This funding will support the development of the Centre for Global Healthcare Innovation to be based in the UK.
New research has revealed that stressful life events are unlikely to cause stroke. Researchers set out to determine the relationship between life events and subarachnoid haemorrhage – the most lethal type of stroke, that is most often due to rupture of aneurysms (‘blisters’) of the blood vessels in the brain. To date, very little evidence exists on this topic.
Medical Innovation 2010 - a leading healthcare innovation conference - will bring together over 300 healthcare professionals, managers, policy makers and researchers for a two-day conference at the Said Business School in Oxford on 17-18 March 2010.
Key findings of the second G-FINDER report, an annual survey of investment into neglected disease R&D, were launched today in New Delhi, India. These show global funding for neglected disease R&D ground to a standstill in 2008.
Researchers at The George Institute have discovered that high consumption of coffee and tea is associated with a substantially reduced risk of type 2 diabetes. Lead author, Associate Professor Rachel Huxley, The George Institute, says that people who consumed on average three to four cups of coffee a day had one-quarter lower risk of developing diabetes compared to non-coffee drinkers.
The new China International Center for Chronic Disease Prevention will focus on research and treatment for the control of conditions such as stroke, heart disease, high blood pressure, kidney disease and diabetes. The Center is hosted by The George Institute, China in partnership with Peking University Health Science Center.